Alzheimer's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with mild cognitive impairment, early symptomatic Alzheimer's disease, Alzheimer's disease, or dementia where Alzheimer's disease is suspected.
- People who are at least 18 years old and have reached the legal age to consent to research procedures in the country or region where the study is taking place.
- People who have a care partner (such as a family member or friend) who spends at least 10 hours per week with them, is willing to take part as a source of information, will attend clinic visits with them, has reached the legal age to consent in the relevant location, and is willing and able to provide their own informed consent as a care partner.
- People who are able to understand the purpose, risks, and voluntary nature of the registry, and are willing and able to give their own informed consent to participate.
- For people enrolling in the United States only: people who are willing and able to provide personal identifying information, including full legal name, sex at birth, date of birth, home address zip code, and social security number (at a minimum).
- People who have been prescribed a commercially available Alzheimer's disease treatment (or a treatment for Alzheimer's disease symptoms) and intend to begin taking it at the time of joining the registry.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are currently participating in, or planning to participate in, a double-blind randomised clinical trial for mild cognitive impairment or Alzheimer's disease.
- People who have previously been treated with an anti-tau therapy (ATT) before joining the registry (confirm with trial site if unsure whether a past treatment qualifies).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Alzheimer Disease Epidemiology and presentation; Alzheimer Disease management, and outcomes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 10 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.